A study casts doubt on the benefits of the Botox to treat migraine
MADRID, 17 ( EUROPA PRESS) a report of the National Institute for excellence and health clinic of United Kingdom (NICE, its acronym in English) has determined that there is not enough scientific evidence that toxin botulinum or Botox, used in the aesthetic treatments to eliminate wrinkles, can be really effective to treat chronic migraine. United States and Europe gave the green light to this indication in 2010. Indeed, the NICE, advising the British Government on approval of medicinal products and medical devices, has been requested to pharmaceuticals that produces this drug, Allergan, to present best clinical data that in June you must decide if it authorizes its use in the national health (NHS) service. “Our independent Committee is asking Allergan to submit information and further as part of this public consultation”, according to Professor Carole Longson, Director of the Center for assessment of technology in health of NICE. Chronic migraine affects 1.6 per cent of elderly people and those who suffer it, periodically present headaches, often accompanied by nausea, vomiting and problems with light and noise. These crises usually last at least 15 days and take place every three months. For the moment, there is no effective treatment to combat this disease that is why, in 2010, the regulatory authorities of United States and Europe give green light to the type developed by Allergan, which must inject at least...
Read More